For the quarter ending 2026-03-31, HTCR made $1,245,844 in revenue. -$1,899,675 in net income. Net profit margin of -152.48%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenues | 1,245,844 | -2,352,869 | 2,990,329 | 4,744,246 |
| Cost of revenues (including cost of revenues resulting from transactions with a related party of 31,328 and 56,523 for the three and six months ended june 30, 2025, respectively, and of 25,117 and 25,117 for the three and six months ended june 30, 2024, respectively) | - | - | - | 2,526,651 |
| Cost of revenues (including cost of revenues resulting from transactions with a related party of 114,535 and 25,195 for the three months ended march 31, 2026 and 2025, respectively) | 1,171,799 | -718,034 | 1,521,920 | - |
| Gross profit | 74,045 | -1,634,835 | 1,468,409 | 2,217,595 |
| Research and development expenses | - | -285,374 | 0 | 161,481 |
| Impairment of intangible asset | - | 0* | - | - |
| Impairment of goodwill | - | 0* | - | - |
| Selling expenses | 42,812 | -537,756 | 94,718 | 385,622 |
| General and administrative expenses (including general and administrative expenses resulting from transactions with a related party of nil and 17,615 for the three months ended march 31, 2026 and 2025, respectively) | 1,571,734 | 1,161,773 | 1,384,838 | 1,563,027 |
| Total operating expenses | 1,614,546 | 338,643 | 1,479,556 | 2,110,130 |
| Loss from continuing operations | -1,540,501 | -1,973,478 | -11,147 | 107,465 |
| Loss on sale of warrants | - | 0* | 0 | - |
| Impairment of investment in equity securities | - | 0* | - | - |
| Changes in fair value of investments in marketable securities | -295,997 | -681,752.5* | 20,539 | - |
| Changes in fair value of investment in warrants | 7,065 | -699,784 | 146,769 | -124,281 |
| Changes in fair value of derivative liability | 870 | -143,459* | 9,679 | - |
| Changes in fair value of investments in marketable securities | - | - | - | 852,709 |
| Loss on forgiveness of note receivable | - | 25,000* | - | - |
| Interest income | 582 | 1,050.5* | 1,046 | 1,841 |
| Interest expenses | 16,625 | 4,779 | 21,083 | 32,665 |
| Other income | 14,095 | 2,981 | 40,332 | 21,561 |
| Other expenses | 112,865 | 144,820 | 6,988 | 17,248 |
| Total other expenses | -418,745 | -9,077 | -122,602 | 950,479 |
| Loss from continuing operations before income tax expense | -1,959,246 | -1,982,555 | -133,749 | 1,057,944 |
| Income tax expense | 17,469 | -11,547 | 3,373 | -3,562 |
| Net loss from continuing operations | -1,976,715 | -3,772,639* | -137,122 | - |
| Loss from discontinued operations, net of income tax | 0 | 10,990,627* | 488,297 | - |
| Net loss | -1,976,715 | 7,217,988 | 351,175 | 1,061,506 |
| Less net loss attributable to non-controlling interests | -105,008 | -128,914 | -82,897 | -38,396 |
| Net loss attributable to heartcore enterprises, inc | -1,871,707 | 7,346,902 | 434,072 | 1,099,902 |
| Dividends accrued on series a convertible preferred shares | 27,968 | 37,524 | 56,222 | 611 |
| Net loss attributable to heartcore enterprises, inc. common shareholders | -1,899,675 | 7,309,378 | 377,850 | 1,099,291 |
| Basic EPS | -1.49 | 0.294 | 0.02 | 0.05 |
| Diluted EPS | -1.49 | 0.298 | 0.02 | 0.04 |
| Basic Average Shares | 1,271,631 | 24,836,368 | 23,310,770 | 22,088,909 |
| Diluted Average Shares | 1,271,631 | 24,548,242 | 28,155,306 | 27,079,975 |
HeartCore Enterprises, Inc. (HTCR)
HeartCore Enterprises, Inc. (HTCR)